MAYSMEDIUM SIGNALFINANCIAL10-K

MAYS showed meaningful improvement in operating performance with substantially reduced losses, though cash position weakened and interest income declined significantly.

The company appears to be on a recovery trajectory with operating losses narrowing considerably and cash flow generation improving substantially. However, the decline in cash reserves and reduced interest income suggests tighter liquidity management, which investors should monitor closely given the company's recent loss-making position.

Comparing 2025-10-23 vs 2024-10-24View on EDGAR →
FINANCIAL ANALYSIS

MAYS demonstrated notable operational improvement with operating losses narrowing meaningfully from -$620K to -$154K while operating cash flow grew substantially to $2.5M. The company reduced total debt by 16.5% but saw cash reserves decline by nearly 40% to $749K, suggesting active capital management. Net interest income fell significantly to $27K, likely reflecting the reduced cash position, though overall net losses improved considerably year-over-year.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+75.7%
$1.4M$2.5M

Operating cash flow surged 75.7% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+75.1%
-$620K-$154K

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Interest Income
P&L
-69.5%
$88K$27K

Net interest income declined 69.5% — margin compression from rate changes or funding cost increases.

Net Income
P&L
+66.5%
-$407K-$136K

Net income grew 66.5% — bottom-line growth signals improving overall business health.

Provision for Credit Losses
P&L
+47.2%
$80K$118K

Credit loss provisions surged 47.2% — management flagging significant deterioration in loan quality ahead.

Cash & Equivalents
Balance Sheet
-39.8%
$1.2M$749K

Cash declined 39.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Total Debt
Balance Sheet
-16.5%
$3.9M$3.2M

Debt reduced 16.5% — deleveraging strengthens balance sheet and reduces financial risk.

LANGUAGE CHANGES
NEW — 2025-10-23
PRIOR — 2024-10-24
ADDED
(Exact Name of Registrant as Specified in Its Charter) New York State or Other Jurisdiction of Incorporation or Organization 11-1059070 I.R.S.
Shulman 83 President November, 1978 Chairman of the Board and Chief Executive Officer November, 1996 Ward N.
The SEC maintains a website that contains reports, proxy and information statements, and other information regarding our filings at http://www.sec.gov.
The Company s actual results, performance or achievements in the future could differ significantly from the results, performance or achievements discussed or implied in such forward-looking statements herein and in prior filings by the Company.
The controlling shareholder group includes a corporation that owns a significant percentage of the Company s common stock and which does business with the Company, as further described in the Notes to the Consolidated Financial Statements contained in the 2025 Annual Report to Shareholders.
+7 more — sign up free →
REMOVED
(Exact Name of Registrant as Specified in Its Charter) New York State or Other Jurisdiction of Incorporation or Organization 9 Bond Street , Brooklyn , New York Address of Principal Executive Offices 11-1059070 I.R.S.
Shulman 82 President November, 1978 Chairman of the Board, Chief Executive Officer and President November, 1996 Ward N.
The Company s actual results, performance or achievements in the future could differ significantly from the results, performance or achievements discussed or implied in such forward-looking statements herein and in prior U.
Securities and Exchange Commission ( SEC ) filings by the Company.
We also may be subject to environmental liability as an owner or operator of properties.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →